Finance

Lists
Q2 2027 earnings • released • EPS miss -11.14% • Revenue beat +6.15%
See results
MARKSANS:NSE
Marksans Pharma Ltd
₹301.00
-4.54%
(-14.30) 1D
Nov 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for MARKSANS...
Open
₹316.90
High
₹327.00
Low
₹296.60
Mkt. cap
136.40B
Avg. vol.
1.71M
Volume
5.96M
Dividend
0.30%
Quarterly dividend
₹0.22
Ex-dividend date
Aug 20, 2026
P/E ratio
26.38
52-wk high
₹350.95
52-wk low
₹155.00
EPS
₹11.41
Shares outstanding
409.31M
No. of employees
2K
Open
₹316.90
High
₹327.00
Low
₹296.60
Mkt. cap
136.40B
Avg. vol.
1.71M
Volume
5.96M
Dividend
0.30%
Quarterly dividend
₹0.22
Ex-dividend date
Aug 20, 2026
P/E ratio
26.38
52-wk high
₹350.95
52-wk low
₹155.00
EPS
₹11.41
Shares outstanding
409.31M
No. of employees
2K
News stories
From web sources and news partners
About Marksans Pharma Ltd
CEOMark B. Saldanha
Employees1.68K
Founded1992
Headquarters-
SectorPharmaceutical industry
Industry-
Websitemarksanspharma.com
Last report
Just released
Today, 12:30 PM
Fiscal period
Q2 2027
₹3.11 / ₹3.50
-11.14%miss
Revenue / Est. (INR)
9.40B / 8.86B
+6.15%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
7.20B
7.54B
8.56B
8.41B
Cost of goods sold
3.09B
3.16B
4.51B
3.43B
Cost of revenue
3.09B
3.16B
4.51B
3.43B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.04B
1.12B
1.21B
1.14B
Operating expense
2.94B
3.02B
2.33B
3.09B
Total operating expenses
6.03B
6.18B
6.85B
6.53B
Operating income
1.18B
1.36B
1.72B
1.88B
Other non operating income
215.72M
201.44M
-441.86M
63.99M
EBT including unusual items
1.33B
1.51B
2.00B
2.07B
EBT excluding unusual items
1.33B
1.51B
1.99B
2.07B
Income tax expense
341.95M
369.34M
509.66M
471.64M
Effective tax rate
25.65%
24.52%
25.48%
22.83%
Other operating expenses
1.64B
1.65B
881.88M
1.70B
Net income
982.50M
1.13B
1.48B
1.57B
Net profit margin
13.64%
15.01%
17.30%
18.69%
Earnings per share
-
2.50
3.27
3.47
Interest and investment income
-
-
276.78M
-
Interest expense
-58.15M
-59.35M
-63.11M
-
Net interest expenses
-58.15M
-59.35M
213.67M
-
Depreciation and amortization charges
269.16M
243.27M
242.88M
248.64M
EBITDA
1.43B
1.50B
1.87B
2.04B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps